View Press Releases
-
COVID-19 could be identified in minutes via mobile technology
AUCKLAND, NEW ZEALAND - Mar 3, 2020 - Fast testing during viral outbreaks, such as the current COVID-19, could assist to prevent its spread, saving lives and money
Mar 2, 2020
-
Olaris Announces Findings from Exploratory Analysis of Biomarkers that Predict Patient Responsiveness to Trastuzumab Therapy
WALTHAM, MA, UNITED STATES - Mar 2, 2020 - Olaris, a precision medicine company that is working to fundamentally change how diseases are treated, today announced the findings from its exploratory analysis of biomarkers of response (BoR) that predict whether a HER2-positive (Her2+) metastatic breast cancer patient will respond to Herceptin® (trastuzumab) therapy
Mar 2, 2020
-
Solentim names Mark Truesdale as new CEO
BOURNEMOUTH, UK - Mar 2, 2020 - Solentim, the global leader in cell line development instrumentation, today announced that Dr Mark Truesdale has been appointed to the position of CEO
Mar 1, 2020
-
Legit™ Unveils A New Collaboration Software For Life Sciences
CAMBRIDGE, MA, UNITED STATES - Feb 28, 2020 - Legit, the leading life sciences collaboration platform, announced today the launch of their new collaboration software geared towards the life sciences
Feb 28, 2020
-
Alfa Chemistry Introduced Functionalized Nanomaterials
NEW YORK, NY - Feb 28, 2020 - On February 20, 2020, Alfa Chemistry announced to introduce a wide range of functionalized nanomaterials to meet the increasing demand from their global customers
Feb 27, 2020
-
Menarini Silicon Biosystems To Announce New Solutions for Advancing Liquid Biopsy in Clinical Research
BOLOGNA, ITALY AND HUNTINGDON VALLEY, PA - Feb 27, 2020 - Menarini Silicon Biosystems, the pioneer of liquid biopsy and rare cell technologies, announced today that it is developing several new products that could help advance precision medicine research by expanding the capabilities and applications of its CELLSEARCH and DEPArray technologies, for rare cells isolation and single cell analysis
Feb 27, 2020
-
Bio Filters For Air Pollution Control Outlook, Product, Industry Developments and Opportunities
ALBANY, NY, US - Feb 27, 2020 - Transparency Market Research delivers key insights on the global bio filter market. In terms of revenue, the global bio filter market is estimated to expand at a CAGR of ~7%, based on value, during the forecast period, owing to numerous factors, regarding which, TMR offers thorough insights and forecasts in the global bio filter market report
Feb 26, 2020
-
Stilla Technologies, Yuzi Holdings and TusPark donate digital PCR Naica™ Systems to help fight coronavirus outbreak in China
SAN FRANCISCO BAY AREA, CA, US - Feb 25, 2020 - Paris, February 25, 2020 - Stilla Technologies, a leading provider of pioneering digital PCR (dPCR) solutions for high-precision genetic analyses, just announced it will be joining an initiative led by Yuzi Holdings and TusPark Science & Technology Service Group (TusPark) to donate two Naica Systems to City of Zhengzhou and City of Xinyang[1], in China, to help them better detect the coronavirus and monitor its mutations
Feb 25, 2020
-
Spring Bank Announces Clinical Collaboration to Evaluate SB 11285 in Combination with PD-L1 Checkpoint Inhibitor in Patients with Advanced Solid Tumors
HOPKINTON, MA, UNITED STATES - Feb 25, 2020 - Spring Bank Pharmaceuticals, Inc. (Nasdaq: SBPH), a clinical-stage biopharmaceutical company developing novel therapeutics for oncology and inflammatory diseases, today announced a new clinical collaboration with Roche (SIX:RO, ROG), to explore the co-administration of SB 11285, Spring Banks intravenously (IV)-administered STING (STimulator of INterferon Gene) agonist with Roches PD-L1 checkpoint inhibitor atezolizumab (Tecentriq®) in patients with advanced solid tumors
Feb 25, 2020
-
The Pistoia Alliance’s UDM Project Reaches Major Milestone
BOSTON, MA, UNITED STATES - Feb 25, 2020 - The Pistoia Alliance, a global, not-for-profit alliance that works to lower barriers to innovation in life sciences R&D, today released the latest Unified Data Model (UDM) file format, Version 6, supported by funding from Biovia, Elsevier, GSK, Novartis, and Roche (recently joined by BMS)
Feb 25, 2020
-
Certara’s Simcyp Division Acquires Modeling and Simulation Platform for Neurodegenerative Diseases from In Silico Biosciences, Inc.
PRINCETON, NJ - Feb 25, 2020 - Certara®, the global model-informed drug development and decision support leader, today reported that it has acquired a range of modeling and simulation technology assets from In Silico Biosciences, Inc
Feb 25, 2020
-
LUNAC Therapeutics selects Domainex as its strategic drug discovery partner
CAMBRIDGE AND LEEDS, UNITED KINGDOM - Feb 25, 2020 - Domainex Ltd., a fully integrated provider of drug discovery services from its Medicines Research Centre near Cambridge, UK, has entered into a research partnership with LUNAC Therapeutics Limited to discover novel anticoagulant therapies that have a reduced risk of bleeding compared to current therapies
Feb 24, 2020
-
Streck to present new tube at TRI-CON
LA VISTA, NE - Feb 24, 2020 - Streck R&D Scientific Manager Dr. Nicholas George will give a presentation on our newest blood collection tube, RNA Complete BCT, at the 27th International Molecular Medicine Tri-Conference in San Francisco
Feb 24, 2020
-
Rare Disease Patient Platform Raremark Partners With TriNetX
CAMBRIDGE, MA - Feb 24, 2020 - TriNetX, the global health research network that revolutionizes clinical research and enables discoveries through the generation of real-world evidence (RWE), today announced that Raremark, a patient-data platform focused on rare disease, has partnered with the TriNetX network to bring more clinical trials to its community
Feb 24, 2020
-
Altair Medical awarded FDA Breakthrough Device designation to address the global opioid crisis
GLASGOW, SCOTLAND - Feb 24, 2020 - Altair Medical, a medical technology company developing a groundbreaking solution to the global opioid crisis, today announce that the US Food and Drug Administration (FDA) has awarded the Company Breakthrough Device designation for its RESPMETER(TM) wearable biosensor device
Feb 24, 2020
-
Aalto Bio Reagents Launches First Recombinant SARS-CoV-2 (COVID-19) Nucleocapsid Protein
DUBLIN, IRELAND - Feb 24, 2020 - Aalto Bio Reagents today announced the availability of its new recombinant SARS-CoV-2 nucleocapsid protein (code CK 6404) for diagnostic test manufacturers, vaccine developers and researchers globally
Feb 24, 2020
-
Creative Diagnostics Introduces Innovative Zebrafish Antibodies
SHIRLEY, NY - Feb 25, 2020 - As a global leading supplier of of raw materials, antibodies, and reagents for bio-technology industry, Creative Diagnostics now launches a large range of antibodies against key immune molecules in zebrafish to enhance the research within the fish scientific community as well as mammalian immune disorders researches
Feb 23, 2020
-
Creative Proteomics Released BrdU Cell Proliferation Assay to Be Behind Researchers
SHIRLEY, NY - Feb 21, 2020 - February 21, 2020, since its establishment in 2004, Creative Proteomics has served nearly 2 million researchers from different areas, including clinical, academia and industry
Feb 20, 2020
-
Absolute Antibody Partners with the Technical University of Denmark to Offer Antibodies against Animal Venom Toxins
REDCAR, UK - Feb 20, 2020 - Absolute Antibody Ltd., an industry-leading provider of recombinant antibody products and services, today announced a partnership with the Technical University of Denmark to develop engineered recombinant antibodies specific for animal toxins, such as toxins from snake venoms
Feb 20, 2020
-
From Ending Addiction to Preventive Genomics, Bio-IT World 2020 Keynoters Share Data-Driven Approaches
NEEDHAM, MA, UNITED STATES - Feb 19, 2020 - Bio-IT World 2020, the premier conference and expo uniting life science, data science, informatics and IT leaders, today announced its Plenary Keynote sessions
Feb 19, 2020